Correlation Between Anebulo Pharmaceuticals and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Atea Pharmaceuticals, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Atea Pharmaceuticals.
Diversification Opportunities for Anebulo Pharmaceuticals and Atea Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Anebulo and Atea is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Atea Pharmaceuticals
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Atea Pharmaceuticals. In addition to that, Anebulo Pharmaceuticals is 2.43 times more volatile than Atea Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest 350.00 in Atea Pharmaceuticals on October 24, 2024 and sell it today you would lose (26.00) from holding Atea Pharmaceuticals or give up 7.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Atea Pharmaceuticals |
Anebulo Pharmaceuticals and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Atea Pharmaceuticals
The main advantage of trading using opposite Anebulo Pharmaceuticals and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |